MSTR Lost Year, Bitcoin Slump Tests Strategy's Bet
MicroStrategy confronts a pivotal test as its Bitcoin treasury faces a brutal market. With BTC below its purchase pri...
After an IRA rollover, selecting the right index fund matters for long-term growth and risk management. Compare options and choose confidently.
26,327 articlesMicroStrategy confronts a pivotal test as its Bitcoin treasury faces a brutal market. With BTC below its purchase pri...
Ethereum confirms FOCIL will join the Hegota upgrade in 2026 while the Ethereum Foundation redirects a portion of its...
DraftKings is diversifying beyond its core betting business. This article examines what that shift could mean for inv...
CrowdStrike’s ARR growth has reaccelerated, but does that make the stock a buy? This guide breaks down ARR health, ma...
XRP remains trapped around $1.45, facing a tough resistance zone between $1.76 and $1.80. On-chain data shows a large...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
The first quarter of 2026 offers clues about corporate health and future growth. This guide explains how to read a go...
The latest Goldman Sachs retirement survey finds a gap between savers’ targets and retirees’ realities, prompting a c...
Hedge fund veteran Michael Burry has added stakes in a high-dividend pharma name and a leading oilfield services comp...
Truth Social’s spot Bitcoin ETF has withdrawn its S-1 filing, signaling tougher market conditions for plain-vanilla c...
Visa now dominates crypto-card payments, handling the vast majority of activity as stablecoins aimed to bypass legacy...